News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
509,504 Results
Type
Article (9026)
Company Profile (142)
Press Release (500245)
Multimedia
Podcasts (5)
Webinars (6)
Section
Business (175014)
Career Advice (386)
Deals (27196)
Drug Delivery (12)
Drug Development (54548)
Employer Resources (18)
FDA (10429)
Job Trends (9230)
News (249629)
Policy (19100)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (662)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (113)
Alliances (35062)
ALS (107)
Alzheimer's disease (1025)
Antibody-drug conjugate (ADC) (270)
Approvals (11102)
Artificial intelligence (339)
ASCO (162)
Autoimmune disease (213)
Automation (30)
Bankruptcy (284)
Best Places to Work (7518)
BIO (37)
Biologics (2)
BIOSECURE Act (3)
Biosimilars (132)
BioSpace Insights (20)
Biotechnology (89)
Bladder cancer (177)
Brain cancer (30)
Breast cancer (519)
Cancer (3845)
Cardiovascular disease (233)
Career advice (324)
Career pathing (5)
CAR-T (180)
CDC (2)
Celiac Disease (1)
Cell therapy (494)
Cervical cancer (34)
Clinical research (49463)
Collaboration (1342)
Commercialization (3)
Compensation (1499)
Complete response letters (34)
COVID-19 (822)
CRISPR (67)
C-suite (824)
Cystic fibrosis (89)
Data (5889)
Denatured (4)
Depression (104)
Dermatology (65)
Diabetes (350)
Diagnostics (4406)
Digital health (39)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (171)
Drug pricing (21)
Drug shortages (2)
Duchenne muscular dystrophy (194)
Earnings (76094)
Editorial (1)
Employer branding (2)
Employer resources (18)
Events (91221)
Executive appointments (762)
FDA (13248)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (964)
Gene editing (133)
Generative AI (13)
Gene therapy (345)
GLP-1 (312)
Government (1085)
Grass and pollen (4)
Guidances (310)
Healthcare (10975)
Hematology (101)
HIV (53)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (101)
Immuno-oncology (57)
Indications (167)
Infectious disease (1017)
Inflammatory bowel disease (129)
Inflation Reduction Act (5)
Influenza (86)
Intellectual property (264)
Interviews (48)
IPO (12844)
IRA (4)
Job creations (2088)
Job search strategy (304)
JPM (2)
Kidney cancer (17)
Labor market (3)
Layoffs (69)
Leadership (2)
Legal (5496)
Licensing (9)
Liver cancer (47)
Longevity (17)
Lung cancer (521)
Lymphoma (266)
Machine learning (27)
Management (3)
Manufacturing (568)
Marketing (10)
MASH (119)
Medical device (9024)
Medtech (9176)
Mergers & acquisitions (15434)
Metabolic disorders (726)
mRNA (61)
Multiple sclerosis (103)
NASH (4)
Neurodegenerative disease (231)
Neuropsychiatric disorders (42)
Neuroscience (1909)
NextGen: Class of 2026 (3575)
Non-profit (1143)
Now hiring (12)
Obesity (233)
Opinion (28)
Ovarian cancer (167)
Pain (175)
Pancreatic cancer (200)
Parkinson's disease (213)
Partnered (13)
Patents (487)
Patient recruitment (524)
Peanut (37)
People (43635)
Pharmaceutical (32)
Pharmacy benefit managers (16)
Phase 1 (15722)
Phase 2 (21924)
Phase 3 (15203)
Pipeline (7733)
Policy (30)
Postmarket research (1649)
Preclinical (6638)
Press Release (34)
Prostate cancer (194)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (649)
Real estate (3326)
Recruiting (10)
Regulatory (15855)
Reports (21)
Research institute (713)
Resumes & cover letters (55)
Rett syndrome (42)
RNA editing (5)
RSV (50)
Schizophrenia (106)
Series A (164)
Series B (125)
Service/supplier (5)
Sickle cell disease (68)
Spinal muscular atrophy (91)
Sponsored (8)
Startups (2124)
Stomach cancer (3)
Supply chain (59)
Tariffs (2)
The Weekly (1)
Vaccines (372)
Venture capital (19)
Weight loss (76)
Women's health (87)
Worklife (1)
Date
Today (52)
Last 7 days (231)
Last 30 days (1658)
Last 365 days (20007)
2026 (12985)
2025 (20186)
2024 (23993)
2023 (27665)
2022 (35976)
2021 (38680)
2020 (35528)
2019 (25943)
2018 (19487)
2017 (20088)
2016 (19248)
2015 (25639)
2014 (22678)
2013 (18832)
2012 (21028)
2011 (21356)
2010 (21083)
Location
Africa (260)
Alabama (77)
Alaska (2)
Arizona (329)
Arkansas (12)
Asia (20068)
Australia (2284)
California (12193)
Canada (3232)
China (550)
Colorado (497)
Connecticut (418)
Delaware (231)
Europe (30313)
Florida (1827)
Georgia (394)
Hawaii (3)
Idaho (47)
Illinois (793)
India (60)
Indiana (354)
Iowa (16)
Japan (504)
Kansas (107)
Kentucky (41)
Louisiana (30)
Maine (26)
Maryland (1223)
Massachusetts (8038)
Michigan (318)
Minnesota (584)
Mississippi (4)
Missouri (110)
Montana (20)
Nebraska (11)
Nevada (117)
New Hampshire (60)
New Jersey (2859)
New Mexico (14)
New York (2896)
North Carolina (1343)
North Dakota (4)
Northern California (6165)
Ohio (291)
Oklahoma (14)
Oregon (17)
Pennsylvania (2372)
Puerto Rico (22)
Rhode Island (32)
South America (469)
South Carolina (78)
South Dakota (1)
Southern California (5016)
Tennessee (146)
Texas (1971)
United States (40237)
Utah (366)
Vermont (1)
Virginia (223)
Washington D.C. (40)
Washington State (937)
West Virginia (1)
Wisconsin (77)
Wyoming (1)
509,504 Results for "vertellus specialties inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Career Advice
From Big Pharma to specialty: why moving closer to the patient changes everything
Working at a Big Pharma has its benefits, but there are limitations too. SERB Pharmaceuticals’ Thomas Kolaras discusses how moving to a midsize company creates new opportunities for sharpened thinking and leadership.
July 22, 2026
·
6 min read
·
Thomas Kolaras
Press Releases
Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe
August 11, 2026
·
4 min read
Press Releases
Roche receives FDA clearance for Elecsys® pTau217, advancing Alzheimer’s disease assessment across primary and specialty care
August 24, 2026
·
9 min read
Press Releases
CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology
July 1, 2026
·
3 min read
Press Releases
Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer’s Disease Pathology in Both Primary and Specialty Care Settings
August 24, 2026
·
5 min read
Press Releases
Laboratory Operations and Technology Innovator Chris Clendening Joins Precision for Medicine to Lead Specialty Labs
July 14, 2026
·
3 min read
Press Releases
Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
August 11, 2026
·
18 min read
Press Releases
NYU Langone Health Once Again Holds the Most No. 1-Ranked Specialties in the Nation in ‘U.S. News & World Report’ Rankings
August 4, 2026
·
3 min read
Press Releases
Orsini to Serve as Contracted Specialty Pharmacy for Gilead’s Hepcludex® (bulevirtide‑gmod)
May 26, 2026
·
2 min read
Press Releases
Midland Industries Acquires Industrial Specialties Manufacturing
March 9, 2026
·
3 min read
1 of 50,951
Next
